> L-Glutamine — Mechanism, Trials & Evidence | OSMF

← All agents | ← Research tracker

L-Glutamine

PubChem entry

Evidence Summary

Evidence Level: Anecdotal
Mechanism: Not specified
Safety: Limited specific safety data in these populations. Review full prescribing information and consult specialist. Many agents used off-label or investigational.
Dosing: See linked studies/trials for reported doses and durations; typical protocols vary widely.
Depletion documented; acute COVID RCT benefit on hospital stay. Alternative TCA substrate. 5-10g/day typical. GI tolerance variable. Supportive for gut/immune recovery; limited PASC-specific data.

Related Conditions

Long COVID (no page yet)

Key Studies / References